Benzinga
...For Popular Weight Loss/Diabetes Drug Tirzepatide Why Is Eli Lilly Stock ...Eli Lilly and Co (NYSE...
On Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes drug tirzepatide. This approval sets the stage for heightened competition with Novo Nordisk ...
5 days ago